{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:41:13Z","timestamp":1785451273346,"version":"3.56.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>DPP4 (dipeptidyl peptidase-4) inhibitors comprise a class of oral diabetes medication that have the potential for off-target cardiovascular effects. We previously showed that DPP4 inhibition attenuates the hypotensive effect of acute ACE (angiotensin-converting enzyme) inhibition and increases norepinephrine. Here, we investigated the effects of DPP4 during sustained ACE inhibition compared with during therapy with an ARB (angiotensin receptor blocker) or calcium channel blocker (neutral comparator) in a randomized, double-blinded crossover study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We enrolled 106 adults with type 2 diabetes and hypertension and 100 received intervention. Subjects were randomized to one of 3 blood pressure arms: ramipril, valsartan, or amlodipine for a total of 15 weeks and received 3 one-week crossover therapies in random order: placebo + placebo, sitagliptin + placebo, and sitagliptin + aprepitant separated by 4-week washout.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We found that DPP4 inhibition increased norepinephrine during ramipril but did not increase blood pressure. Aprepitant, a NK1 (substance P) receptor blocker, lowered standing heart rate during renin-angiotensin-aldosterone system blockade with ramipril or valsartan.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Increased catecholamines during concurrent ACE and DPP4 inhibition may contribute to cardiovascular complications in patients predisposed to heart failure.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/hypertensionaha.121.18348","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T10:00:33Z","timestamp":1642672833000},"page":"827-835","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment"],"prefix":"10.1161","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0402-5830","authenticated-orcid":true,"given":"Jessica R.","family":"Wilson","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacology (J.R.W., S.A.H., C.E.R.B., S.J.K., N.J.B.), Vanderbilt Department of Medicine."},{"name":"Division of Endocrinology, Diabetes, and Metabolism (J.R.W., E.M.G., M.M.), Vanderbilt Department of Medicine."},{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Mayo Clinic Florida (J.R.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8703-2678","authenticated-orcid":true,"given":"Erica M.","family":"Garner","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism (J.R.W., E.M.G., M.M.), Vanderbilt Department of Medicine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0331-2395","authenticated-orcid":true,"given":"Mona","family":"Mashayekhi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism (J.R.W., E.M.G., M.M.), Vanderbilt Department of Medicine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8129-2452","authenticated-orcid":true,"given":"Scott A.","family":"Hubers","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology (J.R.W., S.A.H., C.E.R.B., S.J.K., N.J.B.), Vanderbilt Department of Medicine."},{"name":"Division of Cardiology, Department of Medicine, University of Minnesota (S.A.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1562-6247","authenticated-orcid":true,"given":"Claudia E.","family":"Ramirez Bustamante","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology (J.R.W., S.A.H., C.E.R.B., S.J.K., N.J.B.), Vanderbilt Department of Medicine."},{"name":"Department of Medicine, Baylor College of Medicine (C.E.R.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0256-5251","authenticated-orcid":true,"given":"Scott Jafarian","family":"Kerman","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology (J.R.W., S.A.H., C.E.R.B., S.J.K., N.J.B.), Vanderbilt Department of Medicine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Nian","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University (H.N.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4518-6801","authenticated-orcid":true,"given":"Cyndya A.","family":"Shibao","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology (C.A.S.), Vanderbilt Department of Medicine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7109-3142","authenticated-orcid":true,"given":"Nancy J.","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology (J.R.W., S.A.H., C.E.R.B., S.J.K., N.J.B.), Vanderbilt Department of Medicine."},{"name":"Department of Medicine, Yale School of Medicine (N.J.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-0115(99)00089-0"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2009.48"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.305665"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.11.010"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360105"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307684"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000330"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.07884"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62225-X"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.156554"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00185"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-4347(99)00213-3"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-4347(00)81115-9"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1201\/b17537"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1400"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90738-2"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.71.3.261"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.302589"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199509000-00006"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-001-0093-8"},{"key":"e_1_3_3_22_2","first-page":"169","article-title":"Modulation of sympathetic control by ACE inhibitors.","volume":"14","author":"Dominiak P","year":"1993","unstructured":"Dominiak, P. Modulation of sympathetic control by ACE inhibitors. Eur Heart J. 1993;14:169\u2013172.","journal-title":"Eur Heart J"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/ael268"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00885.2005"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113298"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000130847.18666.39"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M311172200"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M405806200"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi200405c"},{"key":"e_1_3_3_30_2","first-page":"378","article-title":"Radioimmunoassay measurement of substance P release following a meat meal.","volume":"89","author":"Akande B","year":"1981","unstructured":"Akande, B, Reilly, P, Modlin, IM, Jaffe, BM. Radioimmunoassay measurement of substance P release following a meat meal. Surgery. 1981;89:378\u2013383.","journal-title":"Surgery"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00189.2019"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2009.01167.x"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000303"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-0115(86)90048-0"},{"key":"e_1_3_3_35_2","first-page":"143","article-title":"XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors.","volume":"50","author":"Michel MC","year":"1998","unstructured":"Michel, MC, Beck-Sickinger, A, Cox, H, Doods, HN, Herzog, H, Larhammar, D, Quirion, R, Schwartz, T, Westfall, T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev. 1998;50:143\u2013150.","journal-title":"Pharmacol Rev"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.3109\/08037059409102293"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.121.18348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:05:50Z","timestamp":1715594750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.121.18348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.121.18348"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.121.18348","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"2021-09-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}